Sudarshan Kumar
Grant Category: Fulbright-Nehru Academic & Professional Excellence Award (Research & Teaching)
Project Title: Proteomics Based Approaches To Decipher The Antibacterial Mechanisms Of Antimicrobial Peptides (AMPs) against Staphylococcus aureus
Field of Study: Agricultural Sciences
Home Institution: National Dairy Research Institute, Karnal, Haryana
Host Institution: Oregon State University, Corvallis, OR  
Grant Start Month: February, 2023
Duration of Grant: Nine months

Sudarshan Kumar
Brief Bio:

Dr. Sudarshan Kumar is working as senior scientist at National Dairy Research Institute Karnal. He is presently engaged in research related to dairy animal health and production. Over the last 10 years, Dr. Kumar has developed skills in proteomics-based approaches to solve the problems of low milk yield, truncated lactation, mastitis and alternatives to antibiotics in dairy animals. He also develops highly sensitive MS-based methods for the determination of residual veterinary drugs, pesticides and adulterant in milk. He is specialized in molecular cloning, protein expression and purification in a wide range of hosts like bacteria, yeast and mammalian cell which are validated for its function in cell culture models. Recently, in recognition of his work, Dr. Kumar has been conferred the fellowship of the prestigious National Academy of Dairy Sciences.

Currently, his research activities are focused on discovering alternatives to antibiotics. Dr. Kumar’s studies revealed that urogenital tract in animal secrets a large number of endogenous peptides which possesses antimicrobial characteristics and thus keep the organ sterile. However, there are challenges in its clinical application.

The Fulbright-Nehru Visiting Scholar Program involving collaboration between NDRI and Oregon State University aims to understand the mechanism of action behind such AMPs. Specifically, the emphasis is on understanding the molecular crosstalk between antimicrobial peptide and bacterial growth during the tussle to survive and to explore the responsive mechanism of bacteria towards AMPs. In the presence of AMPs, bacterial growth is inhibited. But the final outcome of the battle depends on the potency of AMPs and the SOS response of bacteria. For taking AMPs to the clinical stage, it is essential to understand the SOS response of bacteria. Such knowledge not only helps in the selection of a best AMP but also enables devising strategies to combat antimicrobial resistance.

www.usief.org.in